Lao People's Democratic Republic (the)

in page functions
[French]
Lao PDR
Total population (2017) 7,037,504
Birth cohort (2017) 179,023
Surviving Infants (surviving to 1 year per year, 2017) 172,069
Infant mortality rate (deaths < 1 year per 1000 births, 2015) 51/1000
Child mortality rate (deaths < 5 years per 1000 births, 2015) 67/1000
World Bank Index, IDA (2015) 3.29
Gross Nation Income (per capita US$, 2015) 1,740
Co-financing group (2017) Accelerated transition
No. of districts/territories (2016) 148

Contact Gavi

For more info, contact Gavi country representative officer or email here

Gavi support for Lao PDR

Type of support

Approvals

2001-2021 (US$)
(18 Oct 2017)

Commitments

2001-2021 (US$)
(18 Oct 2017)

Disbursements

2000-2017 (US$)
(18 Oct 2017)

% Disbursed

(18 Oct 2017)
2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020
Total $34,853,794 $36,294,092 $34,915,451
Cash Support (CASHSUPP) $196,500 $221,500 $196,500 100%
Health system strengthening (HSS 1) $438,500 $438,500 $438,500 100%
Health system strengthening (HSS 2) $4,389,698 $4,389,698 $3,996,128 91%
Health system strengthening (HSS 3) $3,555,846 $4,882,144 $2,708,697 76%
HepB mono (NVS) $82,855 $82,855 $82,855 100%
HPV Demo (NVS) $564,181 $564,181 $592,698 105%
Immunisation services support (ISS) $1,431,200 $1,431,200 $1,431,200 100%
Injection Safety Devices (NVS) $60,000 $65,500 $80,679 134%
Injection safety support (INS) $255,505 $255,505 $255,505 100%
IPV (NVS) $899,971 $899,971 $840,375 93%
JEV (NVS) $625,592 $625,592 $625,968 100%
JEV - Operational costs (OPC) $1,047,500 $1,047,500 $1,047,500 100%
MR 2nd dose (NVS) $136,500 $220,000 $75,453 55%
Penta (NVS) $8,815,908 $8,815,908 $9,394,135 107%
Pneumo (NVS) $7,565,924 $7,565,924 $8,361,314 111%
Tetra DTP-HepB (NVS) $3,837,114 $3,837,114 $3,837,114 100%
Vaccine Introduction Grant (VIG) $951,000 $951,000 $950,830 100%

Red line on table indicates duration of support based on commitments.
Commitments: Multi-year programme budgets endorsed in principle by the Gavi Board. These become financial commitments upon approval each year for the following calendar year.
Approvals: Total Approved for funding

Download data for commitments, approvals & disbursements in XLS format

Lao PDR DTP3 / immunisation coverage

DTP3 - WHO/UNICEF estimates (2016)

Grade of confidence


N/A
DTP3 - Official country estimates (2016) 82%
M:F sex ratio at birth (2017) 1.05
Household survey: DTP3 coverage for male (2010) 52.00%
Household survey: DTP3 coverage for female (2010) 53.10%
Household survey: Last DTP3 survey (2014) 81%
% districts achieving > 80% DTP3 coverage (2016) 61%
% districts achieving < 50% DTP3 coverage (2016) 2%
MCV WHO/UNICEF estimates (2016) 76%

Breakdown of support

Non-vaccine support Vaccine support
32% 68%
$11,024,860 $23,890,591

Data refers to disbursed values, date as per above chart

Move mouse over graph for details

News and updates relating to Lao PDR

21 December 2017

2017 letter

2017: responding to global challenges

Letter from Gavi's CEO, Dr Seth Berkley.

29 November 2017

CEO Board update November 2017

Dr Seth Berkley presents an update to the Gavi Board meeting in Vientiane, Lao PDR, reporting on key developments in the global landscape, previous Board decisions and strategic discussion topics.

29 November 2017

Anuradha Gupta, Ngozi Okonjo Iweala, Seth Berkley, Bounkong Syhavong and Somdy Duangby

Gavi and its representatives awarded Medals of labour by Lao PDR president

Gavi honoured for their contribution to immunisation and health system strengthening in the country

close icon

modal window here